A new oral medication treats diabetes and controls insulin levels while simultaneously reversing the inflammatory effects of the disease.

Insulin is a vital hormone produced by pancreatic beta cells. Type 1 diabetes is caused by the destruction of these cells.

Researchers demonstrated that a stem cell-based treatment delivered through an implantable device can produce insulin in the human body.

Researchers show that the overall capacity of fat tissue to respond to insulin is determined by the function of a specific fat cell type